Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Daptomycin Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 350 mg lyophilized powder
  • 1.3.3 500 mg lyophilized powder
• 1.4 Market Segment by Application
  • 1.4.1 Global Daptomycin Market Share by Application (2019-2025)
  • 1.4.2 Adult
  • 1.4.3 Pediatric patients (1 to 17 years of age)
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Daptomycin Market Size
  • 2.1.1 Global Daptomycin Revenue 2014-2025
  • 2.1.2 Global Daptomycin Sales 2014-2025
• 2.2 Daptomycin Growth Rate by Regions
  • 2.2.1 Global Daptomycin Sales by Regions 2014-2019
  • 2.2.2 Global Daptomycin Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Daptomycin Sales by Manufacturers
  • 3.1.1 Daptomycin Sales by Manufacturers 2014-2019
  • 3.1.2 Daptomycin Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Daptomycin Revenue by Manufacturers (2014-2019)
  • 3.2.2 Daptomycin Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Daptomycin Market Concentration Ratio (CR5 and HHI)
• 3.3 Daptomycin Price by Manufacturers
• 3.4 Key Manufacturers Daptomycin Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Daptomycin Market
• 3.6 Key Manufacturers Daptomycin Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 350 mg lyophilized powder Sales and Revenue (2014-2019)
  • 4.1.2 500 mg lyophilized powder Sales and Revenue (2014-2019)
• 4.2 Global Daptomycin Sales Market Share by Type
• 4.3 Global Daptomycin Revenue Market Share by Type
• 4.4 Daptomycin Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Daptomycin Sales by Application

6 United States

• 6.1 United States Daptomycin Breakdown Data by Company
• 6.2 United States Daptomycin Breakdown Data by Type
• 6.3 United States Daptomycin Breakdown Data by Application

7 European Union

• 7.1 European Union Daptomycin Breakdown Data by Company
• 7.2 European Union Daptomycin Breakdown Data by Type
• 7.3 European Union Daptomycin Breakdown Data by Application

8 China

• 8.1 China Daptomycin Breakdown Data by Company
• 8.2 China Daptomycin Breakdown Data by Type
• 8.3 China Daptomycin Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Daptomycin Breakdown Data by Company
• 9.2 Rest of World Daptomycin Breakdown Data by Type
• 9.3 Rest of World Daptomycin Breakdown Data by Application
• 9.4 Rest of World Daptomycin Breakdown Data by Countries
  • 9.4.1 Rest of World Daptomycin Sales by Countries
  • 9.4.2 Rest of World Daptomycin Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Merck & Co.
  • 10.1.1 Merck & Co. Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Daptomycin
  • 10.1.4 Daptomycin Product Introduction
  • 10.1.5 Merck & Co. Recent Development
• 10.2 Pfizer
  • 10.2.1 Pfizer Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Daptomycin
  • 10.2.4 Daptomycin Product Introduction
  • 10.2.5 Pfizer Recent Development
• 10.3 Teva
  • 10.3.1 Teva Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Daptomycin
  • 10.3.4 Daptomycin Product Introduction
  • 10.3.5 Teva Recent Development
• 10.4 Mylan
  • 10.4.1 Mylan Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Daptomycin
  • 10.4.4 Daptomycin Product Introduction
  • 10.4.5 Mylan Recent Development
• 10.5 Fresenius Kabi
  • 10.5.1 Fresenius Kabi Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Daptomycin
  • 10.5.4 Daptomycin Product Introduction
  • 10.5.5 Fresenius Kabi Recent Development
• 10.6 Sagent Pharmaceuticals
  • 10.6.1 Sagent Pharmaceuticals Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Daptomycin
  • 10.6.4 Daptomycin Product Introduction
  • 10.6.5 Sagent Pharmaceuticals Recent Development
• 10.7 Xellia
  • 10.7.1 Xellia Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Daptomycin
  • 10.7.4 Daptomycin Product Introduction
  • 10.7.5 Xellia Recent Development
• 10.8 Hisun
  • 10.8.1 Hisun Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Daptomycin
  • 10.8.4 Daptomycin Product Introduction
  • 10.8.5 Hisun Recent Development
• 10.9 HENGRUI PHARMA
  • 10.9.1 HENGRUI PHARMA Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Daptomycin
  • 10.9.4 Daptomycin Product Introduction
  • 10.9.5 HENGRUI PHARMA Recent Development
• 10.10 Huadong Medicine
  • 10.10.1 Huadong Medicine Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Daptomycin
  • 10.10.4 Daptomycin Product Introduction
  • 10.10.5 Huadong Medicine Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Daptomycin Sales Channels
  • 11.2.2 Daptomycin Distributors
• 11.3 Daptomycin Customers

12 Market Forecast

• 12.1 Global Daptomycin Sales and Revenue Forecast 2019-2025
• 12.2 Global Daptomycin Sales Forecast by Type
• 12.3 Global Daptomycin Sales Forecast by Application
• 12.4 Daptomycin Forecast by Regions
  • 12.4.1 Global Daptomycin Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Daptomycin Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Daptomycin is a lipopeptide antibiotic used in the treatment of systemic and life-threatening infections caused by Gram-positive organisms.
In 2019, the market size of Daptomycin is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Daptomycin.

This report studies the global market size of Daptomycin, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Daptomycin sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Merck & Co.
Pfizer
Teva
Mylan
Fresenius Kabi
Sagent Pharmaceuticals
Xellia
Hisun
HENGRUI PHARMA
Huadong Medicine

Market Segment by Product Type
350 mg lyophilized powder
500 mg lyophilized powder

Market Segment by Application
Adult
Pediatric patients (1 to 17 years of age)

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Daptomycin status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Daptomycin manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Daptomycin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025